Toxicity of nanomaterials; An undermined issue

DARU, Journal of Pharmaceutical Sciences

Volumn 22, Issue 1, 2014, Pages

  Mogharabi, Mehdi ^a   Abdollahi, Mohammad ^a   Faramarzi, Mohammad Ali ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Adverse health effects; Drug delivery; Nanomaterials; Nanomedicine; Toxicity

Indexed keywords

NANOMATERIAL; NANOPARTICLE;

ADVERSE OUTCOME; BLOOD BRAIN BARRIER; BRAIN BLOOD VESSEL; DRUG DELIVERY SYSTEM; HUMAN; IN VITRO STUDY; LYMPH NODE; LYMPH VESSEL; NANOTECHNOLOGY; NERVE CELL DEGENERATION; NONHUMAN; PARTICLE SIZE; PHARMACEUTICS; REVIEW; SKIN PENETRATION; STRATUM CORNEUM; CENTRAL NERVOUS SYSTEM DISEASE; CHEMICALLY INDUCED; IMMUNOPATHOLOGY; LUNG DISEASE;

CENTRAL NERVOUS SYSTEM DISEASES; DRUG DELIVERY SYSTEMS; HUMANS; IMMUNE SYSTEM DISEASES; LUNG DISEASES; NANOSTRUCTURES;

EID: 84908402319     PISSN: 15608115     EISSN: 20082231     Source Type: Journal    
DOI: 10.1186/s40199-014-0059-4     Document Type: Review

References (15)

1. Insights into biogenic and chemical production of inorganic nanomaterials and nanostructures. MA Faramarzi, A Sadighi, Adv Colloid Interface Sci 2013 189-190 1 20 10.1016/j.cis.2012.12.001 23332127
2. Safety concerns to application of graphene compounds in pharmacy and medicine. M Mogharabi, M Abdollahi, MA Faramarzi, Daru 2014 22 23 10.1186/2008-2231-22-23 24450435
3. Toxicity of nanomaterials. S Sharifi, S Behzadi, S Laurent, ML Forrest, P Stroeve, M Mahmoudi, Chem Soc Rev 2012 41 2323 2343 10.1039/c1cs15188f 22170510
4. Nanotechnologies in the food industry recent developments, risks and regulation. M Cushen, J Kerry, M Morris, M Cruz-Romero, E Cummins, Food Sci Technol 2012 24 30 46 10.1016/j.tifs.2011.10.006
5. Clinical developments in nanotechnology for cancer therapy. JD Heidel, ME Davis, Pharm Res 2011 28 187 199 10.1007/s11095-010-0178-7 20549313
6. Penetration of metallic nanoparticles in human full-thickness skin. B Baroli, MG Ennas, F Loffredo, M Isola, R Pinna, MA Lopez-Quintela, J Investig Dermatol 2007 127 1701 1712 17380118
7. Human skin penetration of silver nanoparticles through intact and damaged skin. FF Larese, F D'Agostin, M Crosera, G Adami, N Renzi, M Bovenzi, G Maina, Toxicology 2009 255 33 37 10.1016/j.tox.2008.09.025 18973786
8. Toxic potential of materials at the nanolevel. A Nel, T Xia, L Mädler, N Li, Science 2006 311 622 627 10.1126/science.1114397 16456071
9. Nanoparticles aggravate heat stress induced cognitive deficits, blood-brain barrier disruption, edema formation and brain pathology. HS Sharma, A Sharma, Prog Brain Res 2007 162 245 273 10.1016/S0079-6123(06)62013-X 17645923
10. Barrier capacity of human placenta for nanosized materials. P Wick, A Malek, P Manser, D Meili, X Maeder-Althaus, L Diener, P-A Diener, A Zisch, HF Krug, U von Mandach, Environ Health Perspect 2010 18 432 436
11. Novel harmful effects of [60] fullerene on mouse embryos in vitro and in vivo. T Tsuchiya, I Oguri, YN Yamakoshi, N Miyata, FEBS Lett 1996 393 139 145 10.1016/0014-5793(96)00812-5 8804443
12. Nanoparticles transferred from pregnant mice to their offspring can damage the genital and cranial nerve systems. K Takeda, KI Suzuki, A Ishihara, M Kubo-Irie, R Fujimoto, M Tabata, S Oshio, Y Nihei, T Ihara, M Sugamata, J Health Sci 2009 55 95 102 10.1248/jhs.55.95
13. Different biokinetics of nanomedicines linking to their toxicity; an overview. S Mostafalou, H Mohammadi, A Ramazani, M Abdollahi, Daru 2013 21 14 10.1186/2008-2231-21-14 23432813
14. Current opinion on nanotoxicology. A Pourmand, M Abdollahi, Daru 2012 20 95 10.1186/2008-2231-20-95 23351979
15. The pros and cons of the in-silico phannaco-toxicology in drug discovery and development. S Saeidnia, A Manayi, M Abdollahi, Int J Pharmacol 2013 9 176 181 10.3923/ijp.2013.176.181